Detalhe da pesquisa
1.
DNAJC9 expression in basal-like and luminal A breast cancer subtypes predicts worse survival.
Mol Biol Rep
; 50(9): 7275-7282, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422538
2.
Identification of ALX3 Gene Promoter Hypermethylation as a Potential Biomarker for Lung Cancer.
Anticancer Res
; 43(7): 3029-3036, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351969
3.
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation.
BMC Cancer
; 11: 223, 2011 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21645397
4.
High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer.
Biomark Med
; 15(12): 941-950, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236236
5.
Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma.
Mutat Res
; 684(1-2): 106-8, 2010 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19954744
6.
Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
Breast Cancer
; 27(3): 483-489, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31902119
7.
HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
OMICS
; 21(5): 257-265, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481734
8.
Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma.
Turk J Med Sci
; 46(2): 572-81, 2016 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511526
9.
PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
OMICS
; 19(4): 220-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25831062